RAS mutations in human cancers: Roles in precision medicine
AK Murugan, M Grieco, N Tsuchida - Seminars in cancer biology, 2019 - Elsevier
Ras proteins play a crucial role as a central component of the cellular networks controlling a
variety of signaling pathways that regulate growth, proliferation, survival, differentiation …
variety of signaling pathways that regulate growth, proliferation, survival, differentiation …
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Z Zhang, H Zhang, X Liao, H Tsai - Frontiers in Cell and …, 2023 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. It
has a poor response to conventional therapy and has an extremely poor 5-year survival rate …
has a poor response to conventional therapy and has an extremely poor 5-year survival rate …
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
B Kulemann, S Rösch, S Seifert, S Timme, P Bronsert… - Scientific reports, 2017 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. Circulating tumor cells
(CTC) in the blood are hypothesized as the means of systemic tumor spread. Blood obtained …
(CTC) in the blood are hypothesized as the means of systemic tumor spread. Blood obtained …
Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma
BL Ecker, CM Vollmer, SW Behrman, V Allegrini… - JAMA …, 2019 - jamanetwork.com
Importance Ampullary adenocarcinoma is a rare malignant neoplasm that arises within the
duodenal ampullary complex. The role of adjuvant therapy (AT) in the treatment of ampullary …
duodenal ampullary complex. The role of adjuvant therapy (AT) in the treatment of ampullary …
[HTML][HTML] Kirsten Ras oncogene: significance of its discovery in human cancer research
N Tsuchida, AK Murugan, M Grieco - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract The KRAS/K-RAS oncogene is crucially involved in human cancer. The term
“oncogene”–ie, a gene able to transform a normal cell into a tumor cell–was introduced in …
“oncogene”–ie, a gene able to transform a normal cell into a tumor cell–was introduced in …
[HTML][HTML] Ampullary cancer of intestinal origin and duodenal cancer-A logical clinical and therapeutic subgroup in periampullary cancer
MD Chandrasegaram, AJ Gill, J Samra… - World Journal of …, 2017 - ncbi.nlm.nih.gov
Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At
presentation, the majority of periampullary tumours have grown to involve the pancreas, bile …
presentation, the majority of periampullary tumours have grown to involve the pancreas, bile …
Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis
DW Shin, S Kim, K Jung, JH Jung, B Kim, J Ahn… - European Journal of …, 2023 - Elsevier
Histologically, ampullary carcinomas (ACs) can be classified into intestinal (INT-AC) and
pancreatobiliary (PB-AC) subtypes. However, the prognostic implications of these subtypes …
pancreatobiliary (PB-AC) subtypes. However, the prognostic implications of these subtypes …
Targeting mutated KRAS genes to treat solid tumours
T Krishnan, R Roberts-Thomson, V Broadbridge… - Molecular Diagnosis & …, 2022 - Springer
Kirsten rat sarcoma (KRAS) is one of the most frequently mutated oncogenes in solid
tumours. It encodes an important signalling pathway that drives cellular proliferation and …
tumours. It encodes an important signalling pathway that drives cellular proliferation and …
Ampulla of Vater Carcinoma: sequencing analysis identifies: TP53: Status as a Novel Independent Prognostic factor and potentially actionable ERBB, PI3K, and WNT …
A Mafficini, E Amato, I Cataldo, BC Rusev… - Annals of …, 2018 - journals.lww.com
Objective: To identify molecular prognostic factors and potentially actionable mutations in
ampulla of Vater cancer (AVC). Background: The largely variable outcomes of AVCs make …
ampulla of Vater cancer (AVC). Background: The largely variable outcomes of AVCs make …
KRAS mutations in pancreatic circulating tumor cells: a pilot study
B Kulemann, AS Liss, AL Warshaw, S Seifert… - Tumor Biology, 2016 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is most often diagnosed in a metastatic stage.
Circulating tumor cells (CTC) in the blood are hypothesized as the means of systemic …
Circulating tumor cells (CTC) in the blood are hypothesized as the means of systemic …